These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


2570 related items for PubMed ID: 30201431

  • 1. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.
    Gupta B, Poudel BK, Ruttala HB, Regmi S, Pathak S, Gautam M, Jin SG, Jeong JH, Choi HG, Ku SK, Yong CS, Kim JO.
    Acta Biomater; 2018 Oct 15; 80():364-377. PubMed ID: 30201431
    [Abstract] [Full Text] [Related]

  • 2. Multifunctional mesoporous silica nanoparticles modified with tumor-shedable hyaluronic acid as carriers for doxorubicin.
    Zhang J, Sun Y, Tian B, Li K, Wang L, Liang Y, Han J.
    Colloids Surf B Biointerfaces; 2016 Aug 01; 144():293-302. PubMed ID: 27107383
    [Abstract] [Full Text] [Related]

  • 3. Dual pH-responsive multifunctional nanoparticles for targeted treatment of breast cancer by combining immunotherapy and chemotherapy.
    Liu Y, Qiao L, Zhang S, Wan G, Chen B, Zhou P, Zhang N, Wang Y.
    Acta Biomater; 2018 Jan 15; 66():310-324. PubMed ID: 29129789
    [Abstract] [Full Text] [Related]

  • 4. Hybrid silica-coated Gd-Zn-Cu-In-S/ZnS bimodal quantum dots as an epithelial cell adhesion molecule targeted drug delivery and imaging system.
    Akbarzadeh M, Babaei M, Abnous K, Taghdisi SM, Peivandi MT, Ramezani M, Alibolandi M.
    Int J Pharm; 2019 Oct 30; 570():118645. PubMed ID: 31465835
    [Abstract] [Full Text] [Related]

  • 5. Enzyme-responsive mesoporous silica nanoparticles for tumor cells and mitochondria multistage-targeted drug delivery.
    Naz S, Wang M, Han Y, Hu B, Teng L, Zhou J, Zhang H, Chen J.
    Int J Nanomedicine; 2019 Oct 30; 14():2533-2542. PubMed ID: 31114189
    [Abstract] [Full Text] [Related]

  • 6. Graphene quantum dots-gated hollow mesoporous carbon nanoplatform for targeting drug delivery and synergistic chemo-photothermal therapy.
    Fang J, Liu Y, Chen Y, Ouyang D, Yang G, Yu T.
    Int J Nanomedicine; 2018 Oct 30; 13():5991-6007. PubMed ID: 30323587
    [Abstract] [Full Text] [Related]

  • 7. Hyaluronic acid-modified mesoporous silica-coated superparamagnetic Fe3O4 nanoparticles for targeted drug delivery.
    Fang Z, Li X, Xu Z, Du F, Wang W, Shi R, Gao D.
    Int J Nanomedicine; 2019 Oct 30; 14():5785-5797. PubMed ID: 31440047
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Aerosol technique-based carbon-encapsulated hollow mesoporous silica nanoparticles for synergistic chemo-photothermal therapy.
    Gautam M, Thapa RK, Poudel BK, Gupta B, Ruttala HB, Nguyen HT, Soe ZC, Ou W, Poudel K, Choi HG, Ku SK, Yong CS, Kim JO.
    Acta Biomater; 2019 Apr 01; 88():448-461. PubMed ID: 30818051
    [Abstract] [Full Text] [Related]

  • 10. Mitochondria and nuclei dual-targeted heterogeneous hydroxyapatite nanoparticles for enhancing therapeutic efficacy of doxorubicin.
    Xiong H, Du S, Ni J, Zhou J, Yao J.
    Biomaterials; 2016 Jul 01; 94():70-83. PubMed ID: 27105438
    [Abstract] [Full Text] [Related]

  • 11. Dual-stimuli responsive hyaluronic acid-conjugated mesoporous silica for targeted delivery to CD44-overexpressing cancer cells.
    Zhao Q, Liu J, Zhu W, Sun C, Di D, Zhang Y, Wang P, Wang Z, Wang S.
    Acta Biomater; 2015 Sep 01; 23():147-156. PubMed ID: 25985912
    [Abstract] [Full Text] [Related]

  • 12. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts.
    Zhong Y, Zhang J, Cheng R, Deng C, Meng F, Xie F, Zhong Z.
    J Control Release; 2015 May 10; 205():144-54. PubMed ID: 25596560
    [Abstract] [Full Text] [Related]

  • 13. Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography.
    Feng Q, Zhang Y, Zhang W, Shan X, Yuan Y, Zhang H, Hou L, Zhang Z.
    Acta Biomater; 2016 Jul 01; 38():129-42. PubMed ID: 27090593
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Robust, active tumor-targeting and fast bioresponsive anticancer nanotherapeutics based on natural endogenous materials.
    Sun B, Deng C, Meng F, Zhang J, Zhong Z.
    Acta Biomater; 2016 Nov 01; 45():223-233. PubMed ID: 27576338
    [Abstract] [Full Text] [Related]

  • 16. Quercetin and doxorubicin co-delivery using mesoporous silica nanoparticles enhance the efficacy of gastric carcinoma chemotherapy.
    Fang J, Zhang S, Xue X, Zhu X, Song S, Wang B, Jiang L, Qin M, Liang H, Gao L.
    Int J Nanomedicine; 2018 Nov 01; 13():5113-5126. PubMed ID: 30233175
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Fabricating polydopamine-coated MoSe2-wrapped hollow mesoporous silica nanoplatform for controlled drug release and chemo-photothermal therapy.
    Chai S, Kan S, Sun R, Zhou R, Sun Y, Chen W, Yu B.
    Int J Nanomedicine; 2018 Nov 01; 13():7607-7621. PubMed ID: 30510420
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 129.